September 18, 2024 QuantifiCare v. Canfield Scientific: German Federal Supreme Court Upholds QuantifiCare’s LifeViz® Infinity Patent On July 23, 2024, the German Federal Supreme Court confirmed the validity of the German part of QuantifiCare’s European patent 3 156...
We are thrilled to announce that QuantifiCare has been featured in the latest issue of Prime Journal, a leading publication for aesthetic medicine professionals. The article highlights the cutting-edge technology behind our 3D LifeViz® systems, with a special focus on...
We are excited to announce that QuantifiCare’s innovative 3D LifeViz® Micro system has been prominently featured in a clinical study published in Anti-Âge journal. The study, led by Dr. Sara Gómez-Armayones from Corium Dermatology Clinic, in collaboration with the...
QuantifiCare’s LifeViz® Mini Pro Awarded Best Aesthetic Device 2024 Monaco / March 27th 2024 At QuantifiCare, we are thrilled to announce that our dedication to innovation and excellence has been recognized once again. We have proudly received the Best Aesthetic...
QuantifiCare’s LifeViz Infinity Pro Awarded Best Aesthetic Device Monaco / April 1st 2022 Following the successful launch of its premium, new 3D Aesthetic photography system, QuantifiCare was awarded the Best Aesthetic Device for the LifeViz® Infinity Pro at...
The Partnership Will Utilize QuantifiCare’s DermaPix Mobile™ Image Management Application in Combination with FotoFinder’s DermLite handyscope™ device for Smartphones. ATLANTA, GA – June 25th, 2021– QuantifiCare, the leading provider of validated clinical trial...